Related Experiment Video
Updated: Oct 21, 2025

Comparing Objective Conjunctival Hyperemia Grading and the Ocular Surface Disease Index Score in Dry Eye Syndrome During COVID-19
Published on: May 25, 2022
Investigating the association between allergic diseases and COVID-19 in 400 Iranian patients
Amirhossein Darabi1, Mohammadrezad Dehghanfard2, Sara Jozan3
1Department of Epidemiology, The Persian Gulf Tropical Medicine Research Center, The Persian Gulf Biomedical Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.
Insights
Allergic diseases, particularly allergic rhinitis (AR), were not a risk factor for severe COVID-19. Patients with AR experienced milder COVID-19 symptoms and less severe outcomes compared to those without allergies.
Area of Science:
- Immunology
- Infectious Diseases
- Allergy and Clinical Immunology
Background:
- Allergic diseases are common and may influence susceptibility to infections.
- The role of allergic comorbidity in coronavirus disease 2019 (COVID-19) severity remains unclear.
- Investigating the association between allergies and COVID-19 outcomes is crucial for understanding disease pathogenesis.
Purpose of the Study:
- To determine if allergic diseases predispose individuals to COVID-19.
- To assess the association between allergic comorbidity and COVID-19 severity.
- To analyze the clinical manifestations and outcomes of COVID-19 in patients with and without allergic diseases.
Main Methods:
- A cohort of 400 COVID-19 patients was analyzed.
- Allergic diseases were identified using the standard GA²LEN questionnaire.
- COVID-19 severity was assessed using a visual analog scale (VAS) and intensive care unit (ICU) admission data.
Main Results:
- 39.5% of COVID-19 patients had allergic diseases, showing a reverse association with disease severity (P=0.005).
- Allergic rhinitis (AR) was significantly associated with milder COVID-19 (P=0.02).
- Allergic patients had lower rates of hypoxemia and chest CT involvement compared to non-allergic patients (P=0.002 and P=0.003, respectively).
Conclusions:
- Allergic diseases do not predispose individuals to severe COVID-19.
- Allergic rhinitis is linked to milder clinical manifestations and reduced ICU admission in COVID-19 patients.
- Allergies may have a protective effect against severe outcomes in COVID-19.
Introduction:
Allergic diseases could play a role of a predisposing factor for coronavirus disease 2019 (COVID-19). The aim of this study was to investigate allergic comorbidity and its association in COVID-19 patients.
Methods:
Demographic data, clinical manifestations, laboratory reports, and radiologic findings, together with underlying comorbidity of patients, were studies. Allergic diseases were identified by using the standard GA2LEN questionnaire. The severity of COVID-19 was assessed by a visual analog scale (VAS) and an intensive care unit (ICU) report.
Results:
Out of 400 COVID-19 patients admitted in the hospital, 158 (39.5%) presented with different allergic diseases, and a reverse association was observed between having allergic comorbidity and severity of COVID-19 infection (P = 0.005, relative risk = 0.96; 95% Confidence Interval (95% CI): 0.77-1.19). The respective frequency of asthma, allergic rhinitis (AR), chronic rhinosinusitis (CRS), atopic dermatitis, chronic urticaria, and food or drug allergy was 7.3%, 16%, 1.8%, 5%, 10% and 13.3%. Significantly, only AR was reversely associated with the severity of COVID-19 (P = 0.02, relative risk = 0.45; 95% CI: 0.77-1.19). Additionally, 43% of the patients presented hypoxemia, and 93.5% had chest CT scan involvement. Interestingly, patients with allergic diseases had significantly lower hypoxemia and chest CT involvement as compared with non-allergic patients (P = 0.002 and 0.003, respectively).
Conclusion:
The results of this study established that allergic diseases were not determined to be a predisposing factor for the severe acute respiratory syndrome (SARS) due to coronavirus 2 (SARS-CoV-2) infection. Significantly, AR patients developed mild clinical manifestations of COVID-19 and admitted to ICU as compared to non-AR patients.
More Related Videos
06:34A Component-resolved Diagnostic Approach for a Study on Grass Pollen Allergens in Chinese Southerners with Allergic Rhinitis and/or Asthma
Published on: June 4, 2017
06:08Author Spotlight: Advancing Allergic Rhinitis Research with Multicolor Immunofluorescence
Published on: September 22, 2023
Related Concept Videos
Asthma-I: Introduction
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Allergic Reactions
Allergic Drug Reactions
Asthma-III: Symptoms and Complications
Classification of Asthma